Department of Pharmaceutics Institute of Pharmacy, Nirma University, Ahmedabad

Tejal Mehta Lab

Modified and site‑specific drug delivery systems

The group designs micro- and nanocarrier formulations for the oral cavity, the eye, the skin and the vaginal route, and improves the dissolution of poorly soluble drugs.

Prof. Tejal MehtaProfessor and Head, Department of Pharmaceutics

Media milling took clotrimazole from above 31 µm to 264 nm, more than a hundredfold smaller across. From Patel, Sharma and Mehta, AAPS PharmSciTech 2019.

Where a dose goes

Each route asks something different of a formulation: stay put in the mouth, get past the surface of the eye, hold a drug in the skin, cling to mucosa, or wait until the colon. Five stops, with the group's papers for each.

  1. 1 of 5

    Mouth

    Erlotinib liposomal gel for oral squamous cell carcinoma; electrospun nanofibres for locoregional therapy.

    55.27%tumour volume reduction in vivo with chitosan-coated erlotinib liposomal gel, against 38.88% for plain erlotinib gel.

    Liposomal gel

    • Gel base, applied locally in the mouth
    • Liposome: drug inside a lipid bilayer
    • Dashed ring: chitosan coat
  2. 2 of 5

    Eye

    Drug nanocrystals, mesoporous silica nanoparticles, long-acting implants for macular degeneration.

    Mesoporous silica and nanocrystal

    • Silica particle: drug held in its pores
    • Drug nanocrystal: the drug itself, milled to nanometre size
  3. 3 of 5

    Skin

    Tacrolimus nanoparticle hydrogel, clotrimazole lipid nanogel, betamethasone nanocrystals, silver nanoparticle wound film.

    7-foldhigher water solubility of tacrolimus in phosphonate-functionalised mesoporous silica nanoparticles than free drug.

    Nanoparticle hydrogel on skin

    • Hydrogel layer with drug-loaded nanoparticles
    • Outer skin layers, where the drug is meant to stay
  4. 4 of 5

    Vaginal route

    Clotrimazole mucoadhesive film; 3D-printed delivery systems.

    Mucoadhesive film

    • Thin film carrying dispersed drug
    • Mucosal surface the film adheres to
  5. 5 of 5

    Gut and under the tongue

    Colon, stomach, sublingual, and nose to brain.

    7.2 hfor complete release from the colon-targeted metronidazole mini-tablets, with 6.99% released in the first 5 hours.

    Coated mini-tablets

    • Thick outline: coating that holds back release
    • Inner core: the drug-loaded mini-tablet

Funded project, ongoing

Formulation and development of nanofibers using electrospinning technique for locoregional therapy for oral cancer

Treating early oral cancer at the site of the tumour, so that less drug reaches healthy tissue. The group's earlier work loaded erlotinib into liposomes and a gel for local application in the mouth; the current project builds electrospun nanofibre systems for the same purpose.

Grant
≈ ₹57 lakh
Funder
GSBTM, major research project
Project
Nanofiber-based drug delivery system for oral cancer
Status
Ongoing

Localized delivery of erlotinib using liposomal gel formulations for the treatment of oral squamous cell carcinomaHariharan K, Mehta T, Shah J, Dave H, Sami A, Omri A. Int J Pharm 642, 123144 (2023)

Tumour volume reduction in vivo

Erlotinib gels applied locally, compared by formulation

  1. Plain erlotinib gel38.88%
  2. Erlotinib liposomal gel49.19%
  3. Chitosan-coated erlotinib liposomal gel55.27%
Values from the abstract of Hariharan et al., Int J Pharm 2023. Bars drawn to a 0 to 60% scale.

Publications

Prof. Mehta's faculty profile reports more than 100 research papers. PubMed indexes 38 of them with a Nirma University affiliation. Fourteen are listed here, placed on the years they appeared.

  1. 2026, reviewVaginal drug delivery for precision therapy in polyendocrine metabolic ovarian syndromeShah S, Parikh A, Garg S, Mehta T. Expert Opin Drug Deliv 23, 1967-1990
  2. 2026, reviewNext-generation drug delivery for age-related macular degeneration: promise of controlled release formulationsBangar P, Garkal A, Mehta T. Drug Dev Ind Pharm 52, 1686-1699
  3. 2026, reviewMesoporous silica nanoparticles for ocular drug delivery: synthesis, functionalization, and safety insightsPatel L, Mehta T. AAPS PharmSciTech 27(4)
  4. 2024Quality by design driven development of lipid nanoparticles for cutaneous targetingPatel V, Mehta T, Shah J, Soni K. Drug Deliv Transl Res 15, 1393-1410
  5. 2023Localized delivery of erlotinib using liposomal gel formulations for the treatment of oral squamous cell carcinomaHariharan K, Mehta T, Shah J, Dave H, Sami A, Omri A. Int J Pharm 642, 123144
  6. 2022Betamethasone dipropionate nanocrystals: investigation, feasibility and in vitro evaluationPatel V, Mehta TA. AAPS PharmSciTech 23, 197
  7. 2021Development and optimization of asenapine sublingual film using QbD approachDalal R, Shah J, Gorain B, et al., Mehta TA. AAPS PharmSciTech 22, 244
  8. 2021Tacrolimus encapsulated mesoporous silica nanoparticles embedded hydrogel for the treatment of atopic dermatitisParekh K, Hariharan K, Qu Z, et al., Mehta T. Int J Pharm 608, 121079
  9. 2020Formulation of chitosan stabilized silver nanoparticle-containing wound healing filmPansara C, Mishra R, Mehta T, Parikh A, Garg S. J Pharm Sci 109, 2196-2205
  10. 2020Improvement of oral bioavailability of carvedilol by liquisolid compactJhaveri M, Nair AB, Shah J, Jacob S, Patel V, Mehta T. Drug Deliv Transl Res 10, 975-985
  11. 2019Impact of process parameters on particle size in media milling for clotrimazole nanocrystalsPatel V, Sharma OP, Mehta TA. AAPS PharmSciTech 20, 175
  12. 2016Formulation, development and characterization of mucoadhesive film for treatment of vaginal candidiasisMishra R, Joshi P, Mehta T. Int J Pharm Investig 6, 47-55
  13. 2015Design of experiment approach for formulating multi-unit colon-targeted drug delivery systemShah N, Sharma OP, Mehta T, Amin A. Drug Dev Ind Pharm 42, 825-835
  14. 2014Formulation optimization of gastroretentive drug delivery system for allopurinol using experimental designSharma OP, Shah MV, Parikh DC, Mehta TA. Expert Opin Drug Deliv 12, 513-524
Portrait of Prof. Tejal Mehta

Prof. Tejal Mehta

Professor and Head, Department of Pharmaceutics Deputy Director, Internal Quality Assurance Cell, Nirma University PhD, Sardar Patel University, Vallabh Vidyanagar. M.Pharm and B.Pharm, Gujarat University, Ahmedabad

years of teaching, including research, at UG and PG level
27+
research papers in national and international journals
100+
chapters in national and international books
15+
patents filed, 3 of them granted
5
PhD scholars guided
20

Books

  • Practical Manual of Pharmaceutical Engineering1st and 2nd editions
  • Practical Manual of Pharmaceutical Dosage Forms
  • Pharmaceutical Quality Management and Drug Delivery System
  • An Essential Guide in Pharmaceutics

Awards

  • Best Paper Award 2004Association of Pharmaceutical Teachers of India
  • R. V. Patel Best M.Pharm Thesis AwardGuide category
  • Best Professor Award for Overall PerformanceNirma University
  • Long Service AwardNirma University
  • Prof. M. L. Shroff Pharma Recognition AwardTeam Pharma Lok

Funded research

  • Nanofiber-based drug delivery system for oral cancerGSBTM, major, approx. ₹57 lakhOngoing
  • Minor research projectGUJCOST, amount not statedCompleted

Record, books, projects and awards as stated on the Institute of Pharmacy faculty profile, read 17 November 2026.

People

Current members of the group, each pursuing a PhD with Prof. Mehta in the Department of Pharmaceutics.

  • Anam SamiPhD scholar
  • Lajja PatelPhD scholar
  • Shailvi ShahPhD scholar
  • Priya PatelPhD scholar
  • Priyam ThakarPhD scholar

Join the group

Prof. Mehta is a recognised PG and PhD guide of Nirma University. Twenty PhD scholars have completed their research with her. Students interested in M.Pharm or PhD research in pharmaceutics can contact her at the department.

Telephone
079 7165 2716
Office
PG Faculty area, PG-204
Address
Institute of Pharmacy, Nirma University, Sarkhej-Gandhinagar Highway, Ahmedabad 382481